Main Day 2

9:00 AM - 9:45 AM Personalized Medicine and its Repercussions on Pharmacovigilance

Lisa Bernaise, Global Head, Device Safety, Galderma

Lisa Bernaise

Global Head, Device Safety
Galderma

10:00 AM - 10:45 AM Utilizing a Digital World for Adverse Drug Reactions (ADRs) to Increase your Quality Data Globally

Sameer Thapar, , Rutgers University

Sameer Thapar


Rutgers University

11:15 AM - 12:00 PM Strategies for Interpreting Regulations Globally

Francesca Kolitsopoulos, Director, Epidemiology Strategic Implementation Lead, Pfizer

Francesca Kolitsopoulos

Director, Epidemiology Strategic Implementation Lead
Pfizer

12:00 PM - 12:45 PM Spotlight: Asia as a Key Market for Pharmacovigilance

Rahul Khajuria, Director Global Drug Safety Systems & Analytics, United Therapeutics Corporation

Rahul Khajuria

Director Global Drug Safety Systems & Analytics
United Therapeutics Corporation

Rahul Khajuria

Director Global Drug Safety Systems & Analytics
United Therapeutics Corporation

Ale (Maria) Vazquez-Gragg

VP, Global Patient Safety
Intarcia Therapeutics, Inc

Agnieszka Majcher-Dann

Head of Safety Sciences and Policy, Consumer Segment
Johnson and Johnson

2:30 PM - 3:15 PM Mapping out a Risk Management Plan (RMP)

Ale (Maria) Vazquez-Gragg, VP, Global Patient Safety, Intarcia Therapeutics, Inc

Ale (Maria) Vazquez-Gragg

VP, Global Patient Safety
Intarcia Therapeutics, Inc

3:45 PM - 4:30 PM Monitoring EudraVigilance: Your Role and Responsibilities

Agnieszka Majcher-Dann, Head of Safety Sciences and Policy, Consumer Segment, Johnson and Johnson

Agnieszka Majcher-Dann

Head of Safety Sciences and Policy, Consumer Segment
Johnson and Johnson

4:30 PM - 5:15 PM Zeroing in on FAERS: Suggested Fixes to FDA's Adverse Event Database

Susan DiMaggio, Director, Vendor and Alliance Management , Alexion Pharmaceuticals, Inc.

Susan DiMaggio

Director, Vendor and Alliance Management
Alexion Pharmaceuticals, Inc.